Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease-Reference-Cited by-同舟云学术

Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease

Published:2014-04 Issue: Volume: Page:1
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Rajca Sylvie,Grondin Virginie,Louis Edouard,Vernier-Massouille Gwenola,Grimaud Jean-Charle,Bouhnik Yoram,Laharie David,Dupas Jean-Louis,Pillant Helene,Picon Laurence,Veyrac Michel,Flamant Mathurin,Savoye Guillaume,Jian Raymond,Devos Martine,Paintaud Gilles,Piver Eric,Allez Matthieu,Mary Jean Yves,Sokol Harry,Colombel Jean-Frederic,Seksik Philippe

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference37 articles.

1. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

2. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

3. Alterations of the mucosal immune system in inflammatory bowel disease

4. Regulatory T Cells

5. Genetics and pathogenesis of inflammatory bowel disease

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn’s disease;mSystems;2024-08-16

2. The Role of Nondigestible Oligosaccharides in Alleviating Human Chronic Diseases by Regulating the Gut Microbiota: A Review;Foods;2024-07-08

3. Current Knowledge on the Preparation and Benefits of Cruciferous Vegetables as Relates to In Vitro, In Vivo, and Clinical Models of Inflammatory Bowel Disease;Current Developments in Nutrition;2024-05

4. Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review;Microbiological Research;2024-05

5. Strategies for targeting cytokines in inflammatory bowel disease;Nature Reviews Immunology;2024-03-14